European Biopharma Selects IntraLinks to Streamline Clinical Trial Information Exchange
IntraLinks
® (NYSE: IL), a global technology provider of inter-enterprise content management and collaboration solutions, announced that
Actelion Pharmaceuticals Ltd
, an Allschwil/Basel, Switzerland headquartered biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments to serve unmet medical needs, has selected IntraLinks Connect℠ to streamline its documentation exchange during clinical trials.
Prior to engaging IntraLinks, Actelion relied on traditional courier services to facilitate the exchange of sensitive clinical trial documentation between sponsors and participants, resulting in excessive shipping costs and manual processes for tracking and other activities.
To streamline its documentation process and gain efficiency for themselves and their investigators, Actelion chose IntraLinks Connect to provide central clinical trial portals to facilitate the more secure, compliant auditable exchange of site feasibility, study start up, study conduct and study close-out documentation.
IntraLinks Connect’s security, detailed reporting, workflows, and analytics, together with IntraLinks’ knowledgeable professional service support convinced Actelion that IntraLinks provided the best fit to its requirements. “Whilst working with IntraLinks we can see the maturity of its technology and the commitment of the team to support Actelion moving forward in this area,” said Christine Schwenninger, Head of Global Clinical Monitoring, Actelion. “We are looking forward to working closely together with IntraLinks in the coming years.”
“Actelion’s engagement of IntraLinks demonstrates the growing demand for secure information exchange within the clinical trial process,” says Andy Watson, VP of life sciences EMA at IntraLinks. “IntraLinks Connect will provide Actelion greater efficiency, traceability, and security to improve communication, collaboration, and document exchange between everyone involved in the clinical trial.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
